Literature DB >> 24841474

Antibiotics from myxobacteria.

Till F Schäberle1, Friederike Lohr, Alexander Schmitz, Gabriele M König.   

Abstract

Covering: up to the end of 2013. Myxobacteria produce a vast range of structurally diverse natural products with prominent biological activities. Here, we provide a detailed description and judge the potential of all antibiotically active myxobacterial compounds as lead structures, pointing out their particularities and, if known, their mode of action. Thus, the review provides an overview of the potential of specific compounds, suitable for future investigations and possible clinical applications.

Mesh:

Substances:

Year:  2014        PMID: 24841474     DOI: 10.1039/c4np00011k

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  26 in total

1.  Engineering Pseudochelin Production in Myxococcus xanthus.

Authors:  Juliane Korp; Lea Winand; Angela Sester; Markus Nett
Journal:  Appl Environ Microbiol       Date:  2018-10-30       Impact factor: 4.792

2.  Molecular and functional characterization of myxobacteria isolated from soil in India.

Authors:  Shiv Kumar; Arun Kumar Yadav; Priyanka Chambel; Ramandeep Kaur
Journal:  3 Biotech       Date:  2017-05-31       Impact factor: 2.406

3.  Inducing Global Expression of Actinobacterial Biosynthetic Gene Clusters.

Authors:  Meghan A Pepler; Xiafei Zhang; Marie A Elliot
Journal:  Methods Mol Biol       Date:  2022

4.  The need to innovate sample collection and library generation in microbial drug discovery: a focus on academia.

Authors:  Antonio Hernandez; Linh T Nguyen; Radhika Dhakal; Brian T Murphy
Journal:  Nat Prod Rep       Date:  2021-03-04       Impact factor: 13.423

5.  Draft Genome Sequence of Gephyronic Acid Producer Cystobacter violaceus Strain Cb vi76.

Authors:  D Cole Stevens; Jeanette Young; Rory Carmichael; John Tan; Richard E Taylor
Journal:  Genome Announc       Date:  2014-12-11

6.  Heterologous Production of the Marine Myxobacterial Antibiotic Haliangicin and Its Unnatural Analogues Generated by Engineering of the Biochemical Pathway.

Authors:  Yuwei Sun; Zhiyang Feng; Tomohiko Tomura; Akira Suzuki; Seishi Miyano; Takashi Tsuge; Hitoshi Mori; Joo-Won Suh; Takashi Iizuka; Ryosuke Fudou; Makoto Ojika
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

7.  Genetic engineering and heterologous expression of the disorazol biosynthetic gene cluster via Red/ET recombineering.

Authors:  Qiang Tu; Jennifer Herrmann; Shengbiao Hu; Ritesh Raju; Xiaoying Bian; Youming Zhang; Rolf Müller
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

Review 8.  Marine-derived myxobacteria of the suborder Nannocystineae: An underexplored source of structurally intriguing and biologically active metabolites.

Authors:  Antonio Dávila-Céspedes; Peter Hufendiek; Max Crüsemann; Till F Schäberle; Gabriele M König
Journal:  Beilstein J Org Chem       Date:  2016-05-13       Impact factor: 2.883

Review 9.  Biosynthesis of α-pyrones.

Authors:  Till F Schäberle
Journal:  Beilstein J Org Chem       Date:  2016-03-24       Impact factor: 2.883

Review 10.  Antibiotics from predatory bacteria.

Authors:  Juliane Korp; María S Vela Gurovic; Markus Nett
Journal:  Beilstein J Org Chem       Date:  2016-03-30       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.